financetom
Business
financetom
/
Business
/
Valmont Industries Reports Fiscal Q4 Adjusted Earnings, Revenue Rise; Fiscal 2025 Guidance Set
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Valmont Industries Reports Fiscal Q4 Adjusted Earnings, Revenue Rise; Fiscal 2025 Guidance Set
Feb 18, 2025 5:02 AM

07:42 AM EST, 02/18/2025 (MT Newswires) -- Valmont Industries ( VMI ) reported fiscal Q4 adjusted earnings Tuesday of $3.84 per diluted share, up from $3.18 a year earlier.

Analysts polled by FactSet expected $3.63.

Net sales for the quarter ended Dec. 31 were $1.04 billion, up from $1.02 billion a year earlier.

Analysts surveyed by FactSet estimated $1.01 billion.

Valmont said it expects fiscal 2025 EPS in the range of $17.20 to $18.80. Analysts surveyed by FactSet expect $18.06.

Net sales for the current fiscal year is projected to be in the range of $4 billion to $4.20 billion, the company said. Analysts polled by FactSet expect $4.15 billion.

Shares of the company were up more than 1% in recent premarket activity Tuesday.

Price: 324.29, Change: +3.50, Percent Change: +1.1

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Krystal Biotech's Aesthetic Drug Shows Promise in Phase 1 Study for Wrinkle Improvement
Krystal Biotech's Aesthetic Drug Shows Promise in Phase 1 Study for Wrinkle Improvement
Aug 29, 2024
07:59 AM EDT, 08/28/2024 (MT Newswires) -- Krystal Biotech ( KRYS ) subsidiary Jeune Aesthetics said Wednesday that interim data from a phase 1 trial assessing its experimental aesthetic drug KB301 showed positive results. When assessing the decollete region, the company said that 94% of subjects showed at least a one-point improvement in wrinkles at two months, with 28% achieving...
Elevai Labs, Yuva Biosciences File 2 Hair Treatment Patents
Elevai Labs, Yuva Biosciences File 2 Hair Treatment Patents
Aug 29, 2024
08:03 AM EDT, 08/28/2024 (MT Newswires) -- Elevai Labs ( ELAB ) said Wednesday it has filed two hair and scalp vitality patents in collaboration with Yuva Biosciences. The first patent is for a skin, scalp, and hair improvement treatment while the second patent covers the use of exosomes as a delivery system, the company said. Price: 0.3101, Change: -0.01,...
Grown Rogue Subsidiary Begins Operations in New Jersey
Grown Rogue Subsidiary Begins Operations in New Jersey
Aug 29, 2024
08:05 AM EDT, 08/28/2024 (MT Newswires) -- Grown Rogue International ( GRUSF ) , a craft cannabis company, on Wednesday said subsidiary ABCO Garden State, a licensed cannabis cultivator in New Jersey, began Phase I operations. Phase I includes about 8,000 sq ft of flowering canopy, as measured by bench space, that should produce 500 to 600 pounds of craft...
Foot Locker Q2 Earnings: Revenue And EPS Beat, Multiple Store Closures, Inventory Falls 10% And More
Foot Locker Q2 Earnings: Revenue And EPS Beat, Multiple Store Closures, Inventory Falls 10% And More
Aug 29, 2024
Foot Locker, Inc ( FL )  stock tumbled in the premarket session on Thursday. The company reported a second-quarter adjusted EPS loss of 5 cents, beating the analyst consensus estimate of 7-cent loss. Quarterly sales of $1.896 billion beat the street view of $1.888 billion. Also Read: Goldman Sachs Highlights Foot Locker's Digital Rebound And Costco's New Membership Crackdown Total sales increased 1.9%...
Copyright 2023-2026 - www.financetom.com All Rights Reserved